Seattle Biotech Oncothyreon Pays $27 million for Alpine Biosciences

By August 17, 2014 Portfolio Company News

Seattle biotechnology company Oncothyreon has acquired another local firm, Alpine Biosciences, for about $27 million in stock.

Read the Full Article

Leave a Reply